Literature DB >> 9822285

Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes.

I Nordøy1, F Müller, P Aukrust, S S Frøland.   

Abstract

CVID is immunologically characterized by defective antibody production. Various additional immunological abnormalities have been reported, but little is known of the role of adhesion molecules in CVID. In 31 CVID patients serum levels of L-selectin (CD62L), vascular cell adhesion molecule-1 (VCAM-1) (CD106) and intercellular adhesion molecule-1 (ICAM-1) (CD54) were significantly elevated compared with controls. In 15 CVID patients investigated, the number of L-selectin-positive cells was significantly reduced in both CD4+ and CD8+ lymphocytes compared with controls, and these changes were observed in both CD45RA+ and CD45RO+ subsets. In CD19+ lymphocytes the percentage of ICAM-1+ cells was significantly increased compared with controls. Fifty percent of the patients had splenomegaly. These patients demonstrated even higher serum levels of adhesion molecules, a lower percentage of L-selectin-positive and a higher percentage of CD38+ cells in many T lymphocyte subsets compared with both other CVID patients and controls. Finally, in this patient group the percentage of L-selectin-positive CD19+ lymphocytes was significantly reduced compared with both other patients and controls. These findings indicate a state of ongoing T lymphocyte activation in CVID, especially in the subgroup of patients with splenomegaly, which may contribute to the impaired antimicrobial defence observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822285      PMCID: PMC1905097          DOI: 10.1046/j.1365-2249.1998.00719.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Function and regulation of the neutrophil MEL-14 antigen in vivo: comparison with LFA-1 and MAC-1.

Authors:  M A Jutila; L Rott; E L Berg; E C Butcher
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

Review 2.  Cellular abnormalities in common variable immunodeficiency.

Authors:  G P Spickett; A D Webster; J Farrant
Journal:  Immunodefic Rev       Date:  1990

Review 3.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.

Authors:  C G Mullighan; G C Fanning; H M Chapel; K I Welsh
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

5.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.

Authors:  T K Kishimoto; M A Jutila; E L Berg; E C Butcher
Journal:  Science       Date:  1989-09-15       Impact factor: 47.728

6.  Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule display.

Authors:  A Saxon; J V Giorgi; E H Sherr; J M Kagan
Journal:  J Allergy Clin Immunol       Date:  1989-07       Impact factor: 10.793

7.  Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation.

Authors:  M Merkenschlager; L Terry; R Edwards; P C Beverley
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

8.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

9.  Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.

Authors:  J J Wright; D K Wagner; R M Blaese; C Hagengruber; T A Waldmann; T A Fleisher
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

10.  A homing receptor-IgG chimera as a probe for adhesive ligands of lymph node high endothelial venules.

Authors:  S R Watson; Y Imai; C Fennie; J S Geoffroy; S D Rosen; L A Lasky
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  7 in total

1.  T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency.

Authors:  J Litzman; M Vlková; Z Pikulová; D Stikarovská; J Lokaj
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

Authors:  M Vlková; V Thon; M Sárfyová; L Bláha; A Svobodník; J Lokaj; J Litzman
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Successful immunosuppressive therapy with cyclosporine A for posthepatitis B-cell deficiency with activated cytoplasmic interferon--gamma-positive T-lymphocytes.

Authors:  Hiroko Otsubo; Ken Kaito; Yoji Ogasawara; Takaki Shimada; Noriko Usui; Masayuki Kobayashi
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 4.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

5.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

6.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

7.  IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

Authors:  Dominic Paquin-Proulx; Bianca A N Santos; Karina I Carvalho; Myrthes Toledo-Barros; Ana Karolina Barreto de Oliveira; Cristina M Kokron; Jorge Kalil; Markus Moll; Esper G Kallas; Johan K Sandberg
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.